The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
INTERVENTIONS FOR HYPERTENSION AND STROKE
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry
EuroIntervention 2017;13:877-884 published online June 2017. DOI: 10.4244/EIJ-D-17-00042
Martin W. Bergmann1*, MD, PhD, FESC; Timothy R. Betts2, MD, MBChB, FRCP; Horst Sievert3, MD, FESC, FACC, FSCAI; Boris Schmidt4, MD; Evgeny Pokushalov5, MD, PhD; Stephan Kische6, MD; Thomas Schmitz7, MD; Felix Meincke8, MD; Kenneth M. Stein9, MD, FACC, FHRS; Lucas V.A. Boersma10, MD, PhD, FESC; Hüseyin Ince11, MD
1. Cardiologicum Hamburg, Hamburg, Germany; 2. Department of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom; 3. Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt am Main, Germany; 4. Cardioangiologisches Centrum Bethanien (
Aims: While LAA closure has recently been incorporated into both European and US guidelines for stroke prevention, uncertainties regarding post-procedural drug therapy so far limit its ad